コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 that precede the pairing of target DNA with guide RNA.
2 ectly measure the stability of both Cas9 and guide RNA.
3 from enhancer regions and with an individual guide RNA.
4 activity to the previously published single guide RNA.
5 iviral vectors that express Cre and a single-guide RNA.
6 acent motif (PAM) and complementarity to the guide RNA.
7 s to the gene targeted by the co-transfected guide RNA.
8 tivity but that this activity depends on the guide RNA.
9 irs allowing initial target interrogation by guide RNA.
10 od rather than plasmids that encode Cas9 and guide RNAs.
11 patients with CRISPR/Cas9 using one pair of guide RNAs.
12 in uridylation of gRNA precursors and mature guide RNAs.
13 -specific and gRNA-independent sites for two guide RNAs.
14 can easily be scaled up to process multiple guide RNAs.
15 modification characteristic of ribosomal and guide RNAs.
16 complexes to target loci by modified single guide RNAs.
17 on or deletion, and ligation as specified by guide RNAs.
18 n vivo); 16 websites used to generate single-guide RNA; 4 websites for off-target effects; and 382 ar
19 estabilization is mediated, in part, by Cas9/guide RNA affinity for unpaired segments of nontarget st
21 get through base pairing between a synthetic guide RNA and DNA, outperforms zinc-finger proteins and
22 le-stranded DNA targets complementary to the guide RNA and has been applied to programmable genome ed
23 eak at DNA target sites complementary to the guide RNA and has been harnessed for the development of
26 o method for the simultaneous examination of guide RNA and protospacer adjacent motif (PAM) requireme
29 en by complementary base pairing between the guide RNA and target DNA, Cas9-DNA interactions, and ass
30 anism driven by the interactions between the guide RNA and the 14th-17th nucleotide region of the tar
31 e expressing Cas9 and the other expressing a guide RNA and the donor DNA, into newborn mice with a pa
34 repeats (CRISPR)-associated protein 9 (Cas9) guide RNAs and target interrogation are not well defined
35 kage between ADAR's catalytic domain and the guide RNA, and by introducing a mutation in the catalyti
36 rary that consisted of around 123,000 single-guide RNAs, and profiled genes whose loss in tumour cell
38 ing a fluorescent protein, Cas9, and a small guide RNA are used to mimic nonsense PTEN mutations from
41 least 4.8 kb long can be inserted in CRISPR guide RNA at multiple points, allowing the construction
44 structure of AcrIIA4 in complex with single-guide RNA-bound SpyCas9, thereby establishing that AcrII
45 leases target specific DNA sequences using a guide RNA but also require recognition of a protospacer
46 ed a method to photocage the activity of the guide RNA called "CRISPR-plus" (CRISPR-precise light-med
49 -specific Cas9 cassette together with single-guide RNA cassettes and, in one approach, a dystrophin h
53 uide RNA stability and that the nuclear Cas9-guide RNA complex levels limit the targeting efficiency.
54 onic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mou
58 tric and biochemical assays, we studied Cas9/guide RNA complexes with model DNA substrates that mimic
59 associated 9 from Staphylococcus aureus) and guide RNA constructs into an adeno-associated virus vect
66 of Cas9 together with JCPyV-specific single-guide RNA delivered prior to or after JCPyV infection.
67 NA sequencing reveals that recCas9 catalyzes guide RNA-dependent recombination in human cells with an
68 potential off-targets that enables improved guide RNA design and more accurate prediction of Cas9 bi
71 nces similar to those targeted by individual guide RNAs did not reveal significant off-target effects
72 he two nuclease domains of Cas9, to create a guide RNA-directed DNA nick in the context of an in vitr
73 M-proximal region during early steps of Cas9/guide RNA-DNA complex formation, thus additionally desta
75 t retain the ability to be programmed with a guide RNA, do not induce dsDNA breaks, and mediate the d
77 livery of recombinant Cas9 protein and short guide RNA, driving efficient gene targeting in a non-int
79 Finally, GUIDE-seq revealed that truncated guide RNAs exhibit substantially reduced RGN-induced, of
82 uding tissue-specific promoters, multiplexed guide RNA expression, and effector domain fusions to SpC
84 ISPR)-Cas9 endonucleases coupled with paired guide RNAs flanking the mutated Dmd exon23 resulted in e
85 re able to rapidly identify highly effective guide RNAs; focusing germ line-based experiments only on
86 SPR/Cas9 endonuclease system, comprised of a guide RNA for the recognition of a DNA target and the Ca
89 tion of knockout lines by simply injecting a guide RNA (gRNA) and Cas9 mRNA into one-cell stage embry
90 effects of combinatorial mismatches between guide RNA (gRNA) and target nucleotides, both in the see
92 l library of NOR gates that directly convert guide RNA (gRNA) inputs into gRNA outputs, enabling the
94 s improvements, such as modifications to the guide RNA (gRNA) scaffold and the development of gRNA on
97 atient cells, we designed a disease-specific guide RNA (gRNA) targeting the R124H mutation of TGFBI,
100 Cas9 gene editing method is comprised of the guide RNA (gRNA) to target a specific DNA sequence for c
102 at by altering the length of Cas9-associated guide RNA (gRNA) we were able to control Cas9 nuclease a
103 tment with doxycycline and transfection with guide RNA (gRNA), donor DNA and piggyBac transposase res
104 to create a library of 23,409 barcoded dual guide-RNA (gRNA) combinations and then perform a high-th
106 xplore a homing system architecture in which guide RNAs (gRNAs) are multiplexed, increasing the effec
107 GuideScan produces high-density sets of guide RNAs (gRNAs) for single- and paired-gRNA genome-wi
108 ll lines; however, the features of effective guide RNAs (gRNAs) in different organisms have not been
111 set of 8,964 computationally designed unique guide RNAs (gRNAs) targeting all VACV genes will be valu
113 nciple, simultaneously using two CRISPR/Cas9 guide RNAs (gRNAs) that depend on PAM sites generated by
115 l of Parkinson's disease (PD), we identified guide RNAs (gRNAs) that modulate transcriptional network
117 ibe a CRISPR-based system that uses pairs of guide RNAs (gRNAs) to program thousands of kilobase-scal
119 ociated protein 9 (Cas9), including specific guide RNAs (gRNAs), can excise integrated human immunode
126 is shown to functionally replace the natural guide RNA in the CRISPR-Cas9 nuclease system and to medi
127 xpression of Cas9 and the specific targeting guide RNAs in HIV-1-eradicated T-cells protected them ag
128 geted all pairs of 73 cancer genes with dual guide RNAs in three cell lines, comprising 141,912 tests
131 mRNA duplexes for regulation of translation, guide RNA interactions with target RNA for post-transcri
134 on of recombinant Cas9 protein and synthetic guide RNAs into mouse zygotes has been shown to facilita
137 iction model strongly depends on whether the guide RNA is expressed from a U6 promoter or transcribed
140 ports numerous modifications that can enable guide RNA labeling for use in imaging and mechanistic in
142 nuclease has been combined with genome-scale guide RNA libraries for unbiased, phenotypic screening.
143 named "CRISPR EATING" for generating complex guide RNA libraries suitable for CRISPR/Cas9-based appli
144 GuideScan software for the design of CRISPR guide RNA libraries that can be used to edit coding and
145 interspaced palindromic repeat (CRISPR)-Cas9 guide RNA libraries to perform in situ saturating mutage
146 ) activator constructs and lentiviral single guide RNA libraries to target DNase I hypersensitive sit
149 system, we constructed a genome-wide single-guide RNA library to screen for genes required for proli
152 ion in human prostate cancer cells by single guided RNA-mediated targeting activated AKT and increase
153 cophaga bullata, inject these eggs with Cas9/guide RNA mixtures, and transfer injected eggs back into
154 s double-stranded DNA sequences specified by guide RNA molecules and flanked by a protospacer adjacen
155 Cas9's ability to be directed by single 'guide RNA' molecules to target nearly any sequence has b
157 ond CRISPR library was made containing three guide RNAs per construct to target 18 putative transport
159 than others, and we provide a compendium of guide RNAs predicted to have high efficacy in diverse pa
160 anded target sequences using 5'-hydroxylated guide RNAs rather than the 5'-phosphorylated guides used
163 Crystal structures of Cas9 bound to single-guide RNA reveal a conformation distinct from both the a
165 sing electroporation of Cas9 nuclease/single-guide RNA ribonucleoproteins and taking advantage of a s
167 recruitment of VP64 by dCas9 and a modified guide RNA scaffold gRNA2.0 (designated CRISPR-Act2.0) yi
168 ISPR experiments by presenting ten different guide RNA scoring functions in one simple graphical inte
169 ments revealed that single mismatches in the guide RNA seed sequence reduce the target residence time
170 can be integrated with empirical methods for guide RNA selection into a framework for designing CRISP
171 dly progressing, with marked improvements in guide RNA selection, protein and guide engineering, nove
172 ogrammed to target new sites by altering its guide RNA sequence, and its development as a tool has ma
173 iting technique depends on the choice of the guide RNA sequence, which is facilitated by various webs
174 transactivation domains can act as a potent guide RNA sequence-directed inducer or repressor of gene
175 There exist a number of tools to design the guide RNA sequences and predict potential off-target sit
176 o reveal potential methodologies to engineer guide RNA sequences with improved specificity by conside
177 and gene regulation to predict how changing guide RNA sequences, DNA superhelical densities, Cas9 an
179 methodology to simultaneously assess single guide RNA (sgRNA) activity across approximately 1,400 ge
180 tructures of SaCas9 in complex with a single guide RNA (sgRNA) and its double-stranded DNA targets, c
181 ge or up to 13 mismatches between the single guide RNA (sgRNA) and its genomic target, which refines
182 occus pyogenes Cas9 alone or bound to single-guide RNA (sgRNA) and target DNA revealed a bilobed prot
183 ome-engineering tool that relies on a single guide RNA (sgRNA) and the Cas9 enzyme for genome editing
184 vity of 12 de novo-designed single synthetic guide RNA (sgRNA) constructs, and found their cleavage e
187 sequence features that contribute to single guide RNA (sgRNA) efficiency in CRISPR-based screens.
188 ined protein (Cas9) and an engineered single guide RNA (sgRNA) genome editing platform that offers re
189 coccus pyogenes (spCas9) along with a single guide RNA (sgRNA) has emerged as a versatile toolbox for
190 tagged Cas9 and lentivirus encoding a single guide RNA (sgRNA) in primary human lung microvascular EC
192 by microinjection of Cas9 DNA/RNA and single guide RNA (sgRNA) into zygotes to generate modified anim
194 neously delivers the Cas9 protein and single guide RNA (sgRNA) is based on DNA nanoclews, yarn-like D
196 egy for cloning and sequencing paired single guide RNA (sgRNA) libraries and a robust statistical sco
197 platform is simplified by a synthetic single-guide RNA (sgRNA) mimicking the natural dual trans-activ
199 ead (d) Cas9 combined with engineered single guide RNA (sgRNA) scaffolds that bind sets of fluorescen
201 luding target selection; cloning-free single-guide RNA (sgRNA) synthesis; microinjection; validation
202 9 activation complexes to investigate single-guide RNA (sgRNA) targeting rules for effective transcri
203 off-target sites in vitro, we used a single guide RNA (sgRNA) that has been previously shown to effi
204 ither multiple cleavages induced by a single-guide RNA (sgRNA) that targets multiple chromosome-speci
205 -Associated Virus 9 (AAV9) to deliver single-guide RNA (sgRNA) that targets the Myh6 locus exclusivel
206 t Palindromic Repeats system allows a single guide RNA (sgRNA) to direct a protein with combined heli
207 e CRISPR-Cas9 system utilizes a short single guide RNA (sgRNA) to direct the endonuclease Cas9 to vir
209 A at a sequence programmed by a short single-guide RNA (sgRNA), can result in off-target DNA modifica
210 y simply altering the sequence of the single-guide RNA (sgRNA), one can reprogram Cas9 to target diff
211 dCas9) protein assembled with various single-guide RNA (sgRNA), we demonstrated rapid and robust labe
212 (SBH) structure at the 5' end of the single guide RNA (sgRNA), which abrogates the function of CRISP
213 st bioinformatics tools for design of single guide RNA (sgRNA), which determines the efficacy and spe
214 le cut HDR donor, which is flanked by single guide RNA (sgRNA)-PAM sequences and is released after CR
220 (CRISPR)-based genetic screens using single-guide-RNA (sgRNA) libraries have proven powerful to iden
221 f Cas9-encoding mRNA and multiplexing single guide RNAs (sgRNAs) allowed for phenocopy of known mutan
222 n of specific DNA sequences by CRISPR single-guide RNAs (sgRNAs) and fluorescent-protein-fused cataly
223 suffer from interference between the single-guide RNAs (sgRNAs) and from limited gene targeting acti
225 the relative abundance of integrated single guide RNAs (sgRNAs) between populations, which does not
227 en, and up to twenty-four multiplexed single guide RNAs (sgRNAs) can induce mutations in 90% of the m
228 e immune cells, we used high-fidelity single guide RNAs (sgRNAs) designed with an sgRNA design tool (
229 Cas9-fluorescent proteins and cognate single-guide RNAs (sgRNAs) efficiently labeled several target l
230 t chemical alterations to synthesized single guide RNAs (sgRNAs) enhance genome editing efficiency in
232 ess to a database of over 3.4 million single guide RNAs (sgRNAs) for iSTOP (sgSTOPs) targeting 97%-99
233 o accurately predict highly effective single guide RNAs (sgRNAs) for targeting nuclease-dead Cas9-med
234 ed short palindromic repeats (CRISPR) single guide RNAs (sgRNAs) from a single RNA polymerase II or I
235 PR)-based knockout by analysis of 373 single guide RNAs (sgRNAs) in 6 cells lines and show that the o
236 To address this challenge, we design single-guide RNAs (sgRNAs) integrated with up to 16 MS2 binding
237 r, variable activity across different single guide RNAs (sgRNAs) remains a significant limitation.
239 se applications require the design of single guide RNAs (sgRNAs) that are efficient and specific.
240 in native crRNA:tracrRNA duplexes and single guide RNAs (sgRNAs) that direct Cas9 endonuclease activi
241 r, our understanding of how to select single-guide RNAs (sgRNAs) that mediate efficient Cas9 activity
242 with pools of either single or double single guide RNAs (sgRNAs) to downregulate individual genes or
243 ress transcription in eukaryotic cells using guide RNAs (sgRNAs) to target catalytically inactive Cas
245 SITE-Seq), using Cas9 programmed with single-guide RNAs (sgRNAs), to identify the sequence of cut sit
246 ripts of viral RNAs (MS2 and PP7) and single-guide RNAs (sgRNAs), which when co-expressed with a clea
249 the RNA editing enzyme ADAR to an antisense guide RNA, specific adenosines can be converted to inosi
250 we clone CRISPR/cas9 constructs with single-guide RNAs specifically targeting biogenesis processing
251 eering aimed at altering catalytic function, guide RNA specificity, and PAM requirements and reducing
255 This device consists of a self-targeting guide RNA (stgRNA) that repeatedly directs Streptococcus
258 yptophan, facilitating zippering up of 20-bp guide RNA:target DNA heteroduplex on ternary complex for
260 cus pyogenes was pre-complexed with a single guide RNA targeting downstream of the ubiquitously expre
261 veloped a CRISPR screen using ~18,000 single guide RNAs targeting >700 kilobases surrounding the gene
262 As a proof-of-concept, we delivered short guide RNAs targeting 3 genes critical for cardiac physio
263 target effects have been reported for CRISPR guide RNAs targeting genes that are amplified at high co
264 silkworms constitutively expressing Cas9 and guide RNAs targeting the BmNPV immediate early-1 (ie-1)
265 ovirus to deliver the nickase Cas9(D10A) and guide RNAs targeting the breakpoint sequences, and anoth
266 the catalytically inactive Cas9 (dCas9) and guide RNAs targeting the endogenous roX locus in the Dro
267 ant Cas9 protein complexed with a library of guide RNAs targeting unwanted species for cleavage, thus
268 we demonstrate that the class 2 type VI RNA-guided RNA-targeting CRISPR-Cas effector Cas13a (previou
269 -Cas immune systems and characterize its RNA-guided, RNA-targeting activity, including regulation by
271 degrade invasive genetic elements by an RNA-guided, RNA-targeting multisubunit interference complex.
273 n this study demonstrate the utility of Cas9-guide RNA technology as a plant genome editing tool to e
274 h as flexible junctions between helices help guide RNA tertiary folding, the mechanisms through which
275 CRISPR-Cas-mediated genome editing relies on guide RNAs that direct site-specific DNA cleavage facili
276 NAs, we developed a set of aptazyme-embedded guide RNAs that enable small molecule-controlled nucleas
277 enable multiplexed processing and loading of guide RNAs that in turn allow sensitive detection of cel
279 s9 (Type II) system binds and cuts DNA using guide RNAs, though the variables that control its on-tar
280 ferase DNMT3A targeted by co-expression of a guide RNA to any 20 bp DNA sequence followed by the NGG
281 able genome engineering (CREATE), links each guide RNA to homologous repair cassettes that both edit
282 n be directed by an engineered RNA-targeting guide RNA to target and inhibit a human +ssRNA virus, he
283 ems use single Cas endonucleases paired with guide RNAs to cleave complementary nucleic acid targets,
287 isiae revealed that the Exo9 central channel guides RNA to either Rrp6 or Rrp44 using partially overl
289 We identified an efficient OCT4-targeting guide RNA using an inducible human embryonic stem cell-b
292 relative propensities to bind with different guide RNA variants to targeted or off-target sequences.
295 iously undescribed approach involving single guide RNA, we successfully removed large genome rearrang
296 expression of Cas9 and appropriately chosen guide RNAs, we demonstrate cleavage of cccDNA by Cas9 an
297 elf-cleaving catalytic RNAs (aptazymes) into guide RNAs, we developed a set of aptazyme-embedded guid
298 deficient Cas9 protein and sequence-specific guide RNAs, we show high-resolution and selective isolat
299 coccus pyogenes Cas9 endonuclease and single guide RNAs were cointroduced with or without DNA repair
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。